Literature DB >> 12721805

Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural proteins of dengue virus type 4 restrict replication in the brains of mice.

J E Blaney1, G G Manipon, B R Murphy, S S Whitehead.   

Abstract

Using reverse genetics, it is possible to readily add well-defined attenuating mutations to the genome of wild type or incompletely attenuated dengue (DEN) viruses to generate vaccine candidates that exhibit the desired balance between attenuation and immunogenicity. Here, we describe the identification of eight temperature sensitive missense mutations distributed in four non-structural protein genes that specify a 60- to 10,000-fold range of restricted replication in the suckling mouse brain compared to wild type recombinant DEN4 virus. The usefulness of such mutations in flavivirus vaccine design and development is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721805     DOI: 10.1007/s00705-003-0007-y

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  11 in total

Review 1.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 2.  Flavivirus RNA synthesis in vitro.

Authors:  Radhakrishnan Padmanabhan; Ratree Takhampunya; Tadahisa Teramoto; Kyung H Choi
Journal:  Methods       Date:  2015-08-10       Impact factor: 3.608

3.  Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.

Authors:  Alexander E Aleshin; Sergey A Shiryaev; Alex Y Strongin; Robert C Liddington
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

4.  Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

Authors:  Joseph E Blaney; Jennifer M Matro; Brian R Murphy; Stephen S Whitehead
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Characterization of a small plaque variant of West Nile virus isolated in New York in 2000.

Authors:  Yongqing Jia; Robin M Moudy; Alan P Dupuis; Kiet A Ngo; Joseph G Maffei; Greta V S Jerzak; Mary A Franke; Elizabeth B Kauffman; Laura D Kramer
Journal:  Virology       Date:  2007-07-06       Impact factor: 3.616

Review 6.  Targeted mutagenesis as a rational approach to dengue virus vaccine development.

Authors:  Joseph E Blaney; Anna P Durbin; Brian R Murphy; Stephen S Whitehead
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.

Authors:  Randall J Owens; Chang Limn; Polly Roy
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Genome sequence analysis of in vitro and in vivo phenotypes of Bunyamwera and Ngari virus isolates from northern Kenya.

Authors:  Collins Odhiambo; Marietjie Venter; Konongoi Limbaso; Robert Swanepoel; Rosemary Sang
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 9.  Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility.

Authors:  Aaron C Brault
Journal:  Vet Res       Date:  2009-05-01       Impact factor: 3.683

10.  Comparative analysis of full genomic sequences among different genotypes of dengue virus type 3.

Authors:  Chwan-Chuen King; Day-Yu Chao; Li-Jung Chien; Gwong-Jen J Chang; Ting-Hsiang Lin; Yin-Chang Wu; Jyh-Hsiung Huang
Journal:  Virol J       Date:  2008-05-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.